Sign inJoin waitlistJoin the waitlist

NS

Neil Senzer

Radiology / Radiation Oncology

Credentials: ·

Research

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Journal of Clinical Oncology · 2015 · 2,112 citations
Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the…
Journal of Clinical Oncology · 2004 · 650 citations
Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanoma
Journal of Clinical Oncology · 2009 · First of 15 authors · Corresponding · 495 citations

JN
John Nemunaitis
77 papers
CC
Charles Cunningham
13 papers
MB
Minal Barve
12 papers
FB
Francis Brunicardi
9 papers
Michael Nemunaitis
6 papers · 6 as a fellow
RM
Robert Mennel
6 papers
DR
Donald Richards
5 papers
DK
Donald Kufe
4 papers
Gregory Nemunaitis
4 papers
MG
Maurizio Ghisoli
4 papers
Mitchell Magee
4 papers
Nader Hanna
4 papers